Chargement…
| Groupe | Position | Pour | Contre | Abst. | Répartition |
|---|---|---|---|---|---|
| EPP | Pour | 176 | 0 | 5 | |
| S&D | Pour | 127 | 0 | 0 | |
| PfE | Abstention | 21 | 21 | 37 | |
| ECR | Abstention | 5 | 11 | 56 | |
| Renew | Pour | 68 | 0 | 1 | |
| Greens/EFA | Pour | 51 | 0 | 0 | |
| The Left | Pour | 37 | 0 | 2 | |
| Non-attached | Pour | 17 | 3 | 6 | |
| ESN | Contre | 1 | 22 | 1 |
| Pays | Position | Pour | Contre | Abst. | Répartition |
|---|---|---|---|---|---|
| Germany | Pour | 78 | 12 | 1 | |
| France | Pour | 42 | 4 | 28 | |
| Italy | Pour | 42 | 0 | 31 | |
| Spain | Pour | 45 | 6 | 2 | |
| Poland | Pour | 27 | 3 | 18 |
| Date | Vote | Procédure | Résultat | Pour | Contre | Abst. |
|---|---|---|---|---|---|---|
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestvote final | Critical Medicines Act COD | Adopté | 503 | 57 | 108 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 247 · After recital 22 | Critical Medicines Act COD | Rejeté | 224 | 424 | 20 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 256 · After recital 12 |
| Romania | Pour | 27 | 0 | 3 |
| Netherlands | Pour | 22 | 7 | 0 |
| Belgium | Pour | 13 | 2 | 3 |
| Czechia | Pour | 14 | 1 | 5 |
| Greece | Pour | 15 | 4 | 2 |
| Hungary | Pour | 19 | 1 | 0 |
| Portugal | Pour | 17 | 0 | 1 |
| Sweden | Pour | 11 | 3 | 5 |
| Austria | Pour | 14 | 6 | 0 |
| Bulgaria | Pour | 12 | 3 | 1 |
| Denmark | Pour | 12 | 1 | 1 |
| Finland | Pour | 13 | 1 | 1 |
| Slovakia | Pour | 12 | 2 | 0 |
| Ireland | Pour | 13 | 0 | 0 |
| Croatia | Pour | 11 | 0 | 0 |
| Lithuania | Pour | 8 | 0 | 2 |
| Latvia | Pour | 7 | 0 | 2 |
| Slovenia | Pour | 9 | 0 | 0 |
| Estonia | Pour | 6 | 0 | 1 |
| Cyprus | Pour | 5 | 0 | 1 |
| Luxembourg | Pour | 5 | 1 | 0 |
| Malta | Pour | 4 | 0 | 0 |
| Critical Medicines Act COD |
Adopté |
| 362 |
| 259 |
| 34 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 244 · After recital 3 | Critical Medicines Act COD | Rejeté | 227 | 299 | 138 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 187 · Article 23 | Critical Medicines Act COD | Adopté | 527 | 121 | 15 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 178 · Article 22 | Critical Medicines Act COD | Adopté | 529 | 120 | 16 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 170 · Article 21 | Critical Medicines Act COD | Adopté | 525 | 123 | 14 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 250 · Article 16, after § 2 | Critical Medicines Act COD | Rejeté | 141 | 516 | 7 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 257 · Article 3, § 1, point 5 | Critical Medicines Act COD | Adopté | 325 | 284 | 33 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 164 · Amendments by the committee responsible – separate vote | Critical Medicines Act COD | Adopté | 450 | 205 | 8 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 163 · Amendments by the committee responsible – separate vote | Critical Medicines Act COD | Adopté | 528 | 123 | 10 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 162 · Amendments by the committee responsible – separate vote | Critical Medicines Act COD | Adopté | 494 | 152 | 17 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 159 · Amendments by the committee responsible – separate vote | Critical Medicines Act COD | Adopté | 517 | 127 | 15 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest amendement 158 · Amendments by the committee responsible – separate vote | Critical Medicines Act COD | Adopté | 492 | 159 | 14 |
| 20/01/2026 | Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interestvote final amendement 258 · Proposal for rejection | Critical Medicines Act COD | Rejeté | 44 | 600 | 13 |